<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Canavan, Neil</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Zimmet, Paul</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Debating the Options for Type 2 Diabetes Mellitus Prevention</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2008</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2008-10-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">9-10</style></pages><abstract><style  face="normal" font="default" size="100%">This article not only discusses the best treatment option for diagnosed type 2 diabetes mellitus (T2DM), but also the most prudent ways to prevent the onset of diabetes including managing at-risk individuals who (at present) only show evidence of impaired glucose tolerance, insulin resistance, or beta-cell function — so-called “prediabetics.”</style></abstract><number><style face="normal" font="default" size="100%">7</style></number><volume><style face="normal" font="default" size="100%">8</style></volume></record></records></xml>